NCT07822022Not yet recruiting
Implementing Improved Blood Pressure Measurement in General Practice: A Multisite Implementation Trial Using Automated Office Blood Pressure (AOBP)
Source: ClinicalTrials.gov · Last updated 16 Sept 2026
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate whether implementation of guideline-recommended Automated Office Blood Pressure (AOBP) measurement in Australian general practice clinics improves hypertension control among adults aged 18 years and older who are eligible for blood pressure assessment as part of routine clinical care. The study will also evaluate the implementation, sustainability, and health economic impact of AOBP in real-world primary care settings. The main questions it aims to answer are: * Does implementation of AOBP increase the proportion of patients with treated and controlled hypertension compared with the pre-implementation period? * Can AOBP be successfully adopted, implemented, integrated into routine general practice workflows, and maintained over time? Researchers will compare outcomes following implementation of AOBP with routinely collected clinical data from the period before implementation. Participants will: * Provide informed consent and have their AOBP measurements performed during routine general practice visits. * Consent to the collection of AOBP measurement and relevant clinical information from their medical records for study evaluation. * Continue to receive usual clinical care from their general practitioner. General practice staff will receive AOBP training, perform AOBP measurements, and participate in implementation evaluation activities.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 6000 (estimated)
- First submitted
- 9 Sept 2026
- Start date
- Oct 2026
- Primary completion date
- Oct 2029
- Lead sponsor
- Menzies Institute for Medical Research
- Diseases
- High blood pressure
- NCT number
- NCT07822022
What you commit to
- Study type: Interventional
- Planned participants: 6000
- From Oct 2026 to the primary completion date, Oct 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients who are unable to provide informed consent.
- Patients whose participation is deemed clinically inappropriate by the treating general practitioner.
Who the study is looking for
- Patients will be eligible to participate if they meet Australian guideline-recommended criteria for BP measurement, either for absolute CVD risk assessment or for BP assessment as an individual risk factor, and are attending a participating general practice clinic during the study period.
- Eligible participants include:
- Adults attending participating general practice clinics who are eligible for BP measurement for absolute CVD risk assessment, including:
- Adults aged 45 to 79 years without known CVD
- Adults aged 35 to 79 years with diabetes and without known CVD
- First Nations peoples aged 30 to 79 years without known CVD
- Adults eligible for BP assessment as an individual risk factor, including:
- First Nations peoples aged 18 to 29 years
- Adults aged 18 years and over where BP measurement is clinically indicated based on individual risk factors or clinical judgement (e.g. suspected hypertension from BP measurements outside the clinic, obesity, abnormal cholesterol levels, secondary causes of hypertension, or time elapsed since last BP measurement)
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Menzies Institute for Medical Research, University of Tasmania Coordinator of this site? Confirm its status | Hobart | Australia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.